Case Study

Investigating whether the efficacy of bDMARDs is different in people with seropositive and seronegative rheumatoid arthritis
July 30, 2024 | Rheumatoid Arthritis | Kaoru Takase-Minegishi
Dr. Takase-Minegishi's research examines whether serological status affects treatment responses to biological disease-modifying anti-rheumatic drugs.


View all Case Studies